Italy · AIFA medicine catalogue

ARIPIPRAZOLO SANDOZ BV

A source-listed package record. Different packs may share the same medicine name.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
052514015
Form
Polvere e solvente per sospensione iniettabile a rilascio prolungato
Composition / generic term
ARIPIPRAZOLO
Company as listed by source
SANDOZ BV
Source status
Autorizzata
Supply classification
Medicinali soggetti a prescrizione medica limitativa, da rinnovare volta per volta, vendibili al pubblico su prescrizione di centri ospedalieri o di specialisti

Source-listed ingredients

  • ARIPIPRAZOLO — 300 milligrammi

These values do not establish equivalence or a dose recommendation.

Packages

  • 300 MG POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE A RILASCIO PROLUNGATO- 1 FLACONCINO DI POLVERE IN VETRO, 1 FLACONCINO DI SOLVENTE DA 3 ML IN VETRO, 1 SIRINGA CON AGO DI SICUREZZA, 1 SIRINGA MONOUSO, UN ADATTATORE, 3 AGHI DI SICUREZZA

Source and coverage

Open AIFA medicine catalogue

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Italy records →
ARIPIPRAZOLO SANDOZ BV — Italy | Molindra Medicines